SKI Market

Indian Indices

Nifty

25,509.70 -87.95
(-0.34%)

Sensex

83,311.01 0.00
( 0.00%)

Bank Nifty

57,554.25 -272.80
( -0.47%)

Nifty IT

35,337.60 63.05
( 0.18%)

Global Indices

Nasdaq

46,931.02 -400.98
(-0.85%)

Dow Jones

6,741.06 -76.23
(-1.12%)

Hang Seng

50,848.14 635.87
(1.27%)

Nikkei 225

9,736.38 -40.70
(-0.42%)

Forex

USD-INR

88.65 -0.03
(-0.04%)

EUR-INR

101.82 -0.15
(-0.14%)

GBP-INR

115.54 -0.38
(-0.33%)

JPY-INR

0.58 0.00
(-0.08%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kotak Mahindra Bank Ltd

Industry : Banks - Private Sector

BSE Code

ISIN Demat

Book Value()

500247

INE237A01028

629.3650305

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KOTAKBANK

30.94

414281.37

EPS(TTM)

Face Value()

Div & Yield %

67.34

0.12

Back

Aurobindo Pharma consolidated net profit rises 3.80% in the September 2025 quarter

Nov 06,2025

Net profit of Aurobindo Pharma rose 3.80% to Rs 848.45 crore in the quarter ended September 2025 as against Rs 817.38 crore during the previous quarter ended September 2024. Sales rose 7.73% to Rs 8236.96 crore in the quarter ended September 2025 as against Rs 7646.21 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	8236.96	7646.21	8
OPM %	20.37	20.48	-
PBDT	1705.11	1589.74	7
PBT	1275.92	1207.46	6
NP	848.45	817.38	4

25,509.70 -87.95 (-0.34%)

83,311.01 0.00 ( 0.00%)

57,554.25 -272.80 ( -0.47%)

35,337.60 63.05 ( 0.18%)

46,931.02 -400.98 (-0.85%)

6,741.06 -76.23 (-1.12%)

50,848.14 635.87 (1.27%)

9,736.38 -40.70 (-0.42%)

88.65 -0.03 (-0.04%)

101.82 -0.15 (-0.14%)

115.54 -0.38 (-0.33%)

0.58 0.00 (-0.08%)